nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—Skin infection—Tiotropium—chronic obstructive pulmonary disease	0.0738	0.0738	CcSEcCtD
Methyl aminolevulinate—Skin infection—Montelukast—chronic obstructive pulmonary disease	0.0584	0.0584	CcSEcCtD
Methyl aminolevulinate—Eyelid oedema—Formoterol—chronic obstructive pulmonary disease	0.0357	0.0357	CcSEcCtD
Methyl aminolevulinate—Eyelid oedema—Arformoterol—chronic obstructive pulmonary disease	0.0357	0.0357	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Tiotropium—chronic obstructive pulmonary disease	0.0286	0.0286	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.0234	0.0234	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.0226	0.0226	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.0178	0.0178	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.0178	0.0178	CcSEcCtD
Methyl aminolevulinate—Keratitis—Prednisolone—chronic obstructive pulmonary disease	0.015	0.015	CcSEcCtD
Methyl aminolevulinate—Eczema—Montelukast—chronic obstructive pulmonary disease	0.0142	0.0142	CcSEcCtD
Methyl aminolevulinate—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.0137	0.0137	CcSEcCtD
Methyl aminolevulinate—Blister—Prednisolone—chronic obstructive pulmonary disease	0.0135	0.0135	CcSEcCtD
Methyl aminolevulinate—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.013	0.013	CcSEcCtD
Methyl aminolevulinate—Infection—Roflumilast—chronic obstructive pulmonary disease	0.0126	0.0126	CcSEcCtD
Methyl aminolevulinate—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.012	0.012	CcSEcCtD
Methyl aminolevulinate—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.0114	0.0114	CcSEcCtD
Methyl aminolevulinate—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.0109	0.0109	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.0105	0.0105	CcSEcCtD
Methyl aminolevulinate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.01	0.01	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00932	0.00932	CcSEcCtD
Methyl aminolevulinate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00907	0.00907	CcSEcCtD
Methyl aminolevulinate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00838	0.00838	CcSEcCtD
Methyl aminolevulinate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00836	0.00836	CcSEcCtD
Methyl aminolevulinate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00797	0.00797	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00797	0.00797	CcSEcCtD
Methyl aminolevulinate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00795	0.00795	CcSEcCtD
Methyl aminolevulinate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00792	0.00792	CcSEcCtD
Methyl aminolevulinate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.0079	0.0079	CcSEcCtD
Methyl aminolevulinate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00751	0.00751	CcSEcCtD
Methyl aminolevulinate—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00749	0.00749	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.0074	0.0074	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00714	0.00714	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00676	0.00676	CcSEcCtD
Methyl aminolevulinate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0067	0.0067	CcSEcCtD
Methyl aminolevulinate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00662	0.00662	CcSEcCtD
Methyl aminolevulinate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00662	0.00662	CcSEcCtD
Methyl aminolevulinate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00642	0.00642	CcSEcCtD
Methyl aminolevulinate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00642	0.00642	CcSEcCtD
Methyl aminolevulinate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00638	0.00638	CcSEcCtD
Methyl aminolevulinate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00638	0.00638	CcSEcCtD
Methyl aminolevulinate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00632	0.00632	CcSEcCtD
Methyl aminolevulinate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00629	0.00629	CcSEcCtD
Methyl aminolevulinate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00625	0.00625	CcSEcCtD
Methyl aminolevulinate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00625	0.00625	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00621	0.00621	CcSEcCtD
Methyl aminolevulinate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00606	0.00606	CcSEcCtD
Methyl aminolevulinate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00602	0.00602	CcSEcCtD
Methyl aminolevulinate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00597	0.00597	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00586	0.00586	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00565	0.00565	CcSEcCtD
Methyl aminolevulinate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00563	0.00563	CcSEcCtD
Methyl aminolevulinate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00558	0.00558	CcSEcCtD
Methyl aminolevulinate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00553	0.00553	CcSEcCtD
Methyl aminolevulinate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00553	0.00553	CcSEcCtD
Methyl aminolevulinate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00549	0.00549	CcSEcCtD
Methyl aminolevulinate—Pain—Formoterol—chronic obstructive pulmonary disease	0.00549	0.00549	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00544	0.00544	CcSEcCtD
Methyl aminolevulinate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00542	0.00542	CcSEcCtD
Methyl aminolevulinate—Pain—Montelukast—chronic obstructive pulmonary disease	0.00538	0.00538	CcSEcCtD
Methyl aminolevulinate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00532	0.00532	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00531	0.00531	CcSEcCtD
Methyl aminolevulinate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00528	0.00528	CcSEcCtD
Methyl aminolevulinate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00526	0.00526	CcSEcCtD
Methyl aminolevulinate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00523	0.00523	CcSEcCtD
Methyl aminolevulinate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00518	0.00518	CcSEcCtD
Methyl aminolevulinate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.0051	0.0051	CcSEcCtD
Methyl aminolevulinate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.0051	0.0051	CcSEcCtD
Methyl aminolevulinate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00501	0.00501	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00501	0.00501	CcSEcCtD
Methyl aminolevulinate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00501	0.00501	CcSEcCtD
Methyl aminolevulinate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00499	0.00499	CcSEcCtD
Methyl aminolevulinate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00498	0.00498	CcSEcCtD
Methyl aminolevulinate—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00496	0.00496	CcSEcCtD
Methyl aminolevulinate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00481	0.00481	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00473	0.00473	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00473	0.00473	CcSEcCtD
Methyl aminolevulinate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00472	0.00472	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00463	0.00463	CcSEcCtD
Methyl aminolevulinate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00461	0.00461	CcSEcCtD
Methyl aminolevulinate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00461	0.00461	CcSEcCtD
Methyl aminolevulinate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Methyl aminolevulinate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Methyl aminolevulinate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00451	0.00451	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00447	0.00447	CcSEcCtD
Methyl aminolevulinate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Methyl aminolevulinate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00435	0.00435	CcSEcCtD
Methyl aminolevulinate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00429	0.00429	CcSEcCtD
Methyl aminolevulinate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00426	0.00426	CcSEcCtD
Methyl aminolevulinate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00424	0.00424	CcSEcCtD
Methyl aminolevulinate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00424	0.00424	CcSEcCtD
Methyl aminolevulinate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00416	0.00416	CcSEcCtD
Methyl aminolevulinate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00405	0.00405	CcSEcCtD
Methyl aminolevulinate—Rash—Formoterol—chronic obstructive pulmonary disease	0.00405	0.00405	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Methyl aminolevulinate—Headache—Formoterol—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Methyl aminolevulinate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Methyl aminolevulinate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00401	0.00401	CcSEcCtD
Methyl aminolevulinate—Rash—Montelukast—chronic obstructive pulmonary disease	0.00396	0.00396	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00396	0.00396	CcSEcCtD
Methyl aminolevulinate—Headache—Montelukast—chronic obstructive pulmonary disease	0.00394	0.00394	CcSEcCtD
Methyl aminolevulinate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00382	0.00382	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00382	0.00382	CcSEcCtD
Methyl aminolevulinate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00381	0.00381	CcSEcCtD
Methyl aminolevulinate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00381	0.00381	CcSEcCtD
Methyl aminolevulinate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0038	0.0038	CcSEcCtD
Methyl aminolevulinate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00373	0.00373	CcSEcCtD
Methyl aminolevulinate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0036	0.0036	CcSEcCtD
Methyl aminolevulinate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00358	0.00358	CcSEcCtD
Methyl aminolevulinate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00348	0.00348	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00332	0.00332	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00312	0.00312	CcSEcCtD
Methyl aminolevulinate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Methyl aminolevulinate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.00297	CcSEcCtD
Methyl aminolevulinate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Methyl aminolevulinate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.0026	0.0026	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Methyl aminolevulinate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Methyl aminolevulinate—Infection—Prednisone—chronic obstructive pulmonary disease	0.00251	0.00251	CcSEcCtD
Methyl aminolevulinate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Methyl aminolevulinate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Methyl aminolevulinate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Methyl aminolevulinate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Methyl aminolevulinate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Methyl aminolevulinate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00201	0.00201	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Methyl aminolevulinate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Methyl aminolevulinate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00179	CcSEcCtD
Methyl aminolevulinate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Methyl aminolevulinate—Rash—Prednisone—chronic obstructive pulmonary disease	0.00159	0.00159	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00159	0.00159	CcSEcCtD
Methyl aminolevulinate—Headache—Prednisone—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Methyl aminolevulinate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.0015	0.0015	CcSEcCtD
